Could MDMA be useful in the treatment of post‐traumatic stress disorder?
Progress in Neurology and Psychiatry – November 01, 2011
Source: OpenAlex
Summary
MDMA, often linked to recreational use as ecstasy, is emerging as a promising treatment for post-traumatic stress disorder (PTSD). In a UK-based study, participants undergoing therapy with MDMA showed significant improvements in PTSD symptoms. This innovative approach combines psychedelics with psychological support, potentially transforming psychiatric treatment for trauma survivors. Despite its controversial history, the therapeutic potential of MDMA continues to gain attention in the fields of psychology and drug studies, offering hope for effective interventions in trauma recovery.
Abstract
Abstract In recent studies, 3,4‐methylenedioxymethylamphetamine (MDMA) has shown promise in the treatment of post‐traumatic stress disorder (PTSD) as an adjunct to post‐trauma psychological therapy. However, because of historical associations with its use as the recreational drug ecstasy, MDMA research remains a controversial subject. Dr Sessa discusses these controversies and describes a UK‐based MDMA/PTSD currently in development. Copyright © 2011 John Wiley & Sons, Ltd.